Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells. - Wikidata - wikimedia - TriplyDB

Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells.

Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells.

http://www.wikidata.org/entity/Q34369138

about

Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide Tamoxifen Resistance: Emerging Molecular Targets Targeting the androgen receptor in prostate and breast cancer: several new agents in development Molecular phenotypes in triple negative breast cancer from African American patients suggest targets for therapy Deciphering the divergent roles of progestogens in breast cancer.Posttranslationally modified progesterone receptors direct ligand-specific expression of breast cancer stem cell-associated gene programs Importance of Breast Cancer Subtype in the Development of Androgen Receptor Directed Therapy.Phosphorylation of androgen receptors at serine 515 is a potential prognostic marker for triple negative breast cancer Androgen receptor genotypes predict response to endocrine treatment in breast cancer patients.Abiraterone acetate, exemestane or the combination in postmenopausal patients with estrogen receptor-positive metastatic breast cancer AR collaborates with ERα in aromatase inhibitor-resistant breast cancer.Dicer-mediated upregulation of BCRP confers tamoxifen resistance in human breast cancer cells.Prosaposin activates the androgen receptor and potentiates resistance to endocrine treatment in breast cancer.Contribution of Estrone Sulfate to Cell Proliferation in Aromatase Inhibitor (AI) -Resistant, Hormone Receptor-Positive Breast Cancer.Minireview: The androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene?In vitro mechanism for downregulation of ER-α expression by epigallocatechin gallate in ER+/PR+ human breast cancer cells The Role of Androgen Receptor in Breast Cancer.The growth response to androgen receptor signaling in ERα-negative human breast cells is dependent on p21 and mediated by MAPK activation Androgen receptor expression predicts beneficial tamoxifen response in oestrogen receptor-α-negative breast cancer Androgen receptor promotes tamoxifen agonist activity by activation of EGFR in ERα-positive breast cancer BRCA1 inhibits AR-mediated proliferation of breast cancer cells through the activation of SIRT1 Mechanisms of endocrine resistance in breast cancer.Expression of Androgen Receptor in Estrogen Receptor-positive Breast Cancer.Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures.Androgens Regulate T47D Cells Motility and Invasion through Actin Cytoskeleton Remodeling.Expression of androgen receptor and its phosphorylated forms in breast cancer progression.The rs4646 and rs12592697 Polymorphisms in CYP19A1 Are Associated with Disease Progression among Patients with Breast Cancer from Different Racial/Ethnic Backgrounds.Differential impact of the expression of the androgen receptor by age in estrogen receptor-positive breast cancer.Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer.Prognostic value of androgen receptor in triple negative breast cancer: A meta-analysis β-D-glucan inhibits endocrine-resistant breast cancer cell proliferation and alters gene expression AR Signaling in Breast Cancer.Postmenopausal breast cancer, androgens, and aromatase inhibitors.Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysis.Emerging strategies to overcome resistance to endocrine therapy for breast cancer.Molecular markers for breast cancer diagnosis, prognosis and targeted therapy.Targeting the androgen receptor in breast cancer.Clinical importance of androgen receptor in breast cancer patients treated with adjuvant tamoxifen monotherapy.Cooperative Dynamics of AR and ER Activity in Breast Cancer.Testosterone membrane-initiated action in breast cancer cells: Interaction with the androgen signaling pathway and EPOR.

P2860

Q21195191-7D7B70CE-26AB-4795-912A-3F7B3441D7F3 Q26739969-075DE79A-41BC-4AB9-B94B-3EC4D88EFB87 Q27009424-E2339266-A369-4200-8B5F-11A56C9A3AC3 Q28535227-7C9AD529-ECEC-4905-BCA4-B806F804BD80 Q30240711-02083F1A-128D-4F52-A35D-6B3024EE9FA5 Q33568421-87D822AB-BE8F-4883-883E-028F6C8778F7 Q33632582-1BA54256-C46E-48F2-ADF2-A108EBA82250 Q33913872-EBB69FF3-C6D5-4047-BF87-F43758A09A2D Q34228066-8B12E2AD-E5C2-4FB0-9593-566DD86F00C3 Q34499512-97FA94CC-B943-4C05-8044-544F283BB948 Q35112392-3E24A3DA-AE45-4F4E-ACA7-61E33F69A0C1 Q35762594-F427A02B-A278-45F4-BB53-8D73E3DD70B1 Q36030567-DC382EAC-AFAC-468B-BBA2-360691315078 Q36030787-AF6F7368-2F93-445D-925B-B7119A6EBC69 Q36113793-B2FC286D-7E29-4AD7-879F-60880EEEC5CC Q36274172-D2FA459E-4284-4C6C-BA92-810460B8BBB2 Q36275556-9C403189-B1DF-4C08-999C-3715AB27CEF4 Q36393201-F330BB9F-C36F-4E1E-88C0-18B47643AFB5 Q36547919-E12AE4FB-BAA4-43F8-ADC0-23BD50623DA8 Q36568006-52232DA2-14FF-43B8-A6CF-16FFBA70A63E Q36605853-DC26B395-7187-4B1D-A96D-D0118A5B6A82 Q36851417-CBCA41C8-D0DF-4CB9-A2D0-7B70657DAE51 Q37229990-697B774A-01A5-471B-8383-F4CEA9EBFE41 Q37281532-844DA39A-3E9B-4D45-B83A-409BFB32D309 Q37298916-E1FD4F25-7990-4BCF-BF70-EEA3F18AEB6C Q37418745-27CCDD79-AC94-4FE8-AEE1-262C01AC689A Q37463634-DF56773D-5B21-4C0F-948A-91237C6BA162 Q37481133-770E4E8C-A5DA-4E14-AC51-7A21FCF7E57A Q37533025-B15D77A3-CA95-4BB1-A107-645D9867133D Q37564779-64BC154D-8EF3-43C5-A0C3-15A687F0E91F Q37688662-DF8C1EA9-BD2C-4E63-8FD8-BB836C762DC6 Q37721492-D3F60CBF-4CA5-478B-ACF3-4624F6329B63 Q38097730-88DE28E9-3DF6-45D6-B203-35EFE3478D23 Q38165914-7869E461-CF9F-4BB3-8DE8-E67F9D6B01B4 Q38221463-F48ECC61-7BD5-4917-9D72-F1A6DC7C7D79 Q38236904-E6A1B26C-0C2B-4E17-8974-D94C2DB9B5FA Q38349376-ED1B123F-31E3-4AB3-A88F-D20FD479501A Q38405459-89454E9E-8FAD-4633-BC70-EE3E3544C2CB Q38749913-7198E6D8-258D-4DA2-A195-7F0B048C2719 Q39734169-0F7FE35E-5AC6-4022-B00D-657DC6C33ADA

P2860

Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells.

http://www.wikidata.org/entity/Q34369138

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Androgen receptor overexpressi ...... in human breast cancer cells.

@ast

Androgen receptor overexpressi ...... in human breast cancer cells.

@en

Androgen receptor overexpressi ...... in human breast cancer cells.

@nl

type

label

Androgen receptor overexpressi ...... in human breast cancer cells.

@ast

Androgen receptor overexpressi ...... in human breast cancer cells.

@en

Androgen receptor overexpressi ...... in human breast cancer cells.

@nl

prefLabel

Androgen receptor overexpressi ...... in human breast cancer cells.

@ast

Androgen receptor overexpressi ...... in human breast cancer cells.

@en

Androgen receptor overexpressi ...... in human breast cancer cells.

@nl

P1433

Q34369138-89143865-13F6-4F32-92A3-B9508E03C43C

P1476

Q34369138-4A31BE73-FD74-4DA8-91FF-71E15B3F8A91

P2093

Q34369138-1D70110F-D5E4-4F37-A511-D5706C1B753B

Q34369138-3D94B5F5-D1B4-40BB-A213-2D47C6FC4441

Q34369138-418F890F-E068-4D56-AD6C-11E12DD91D6E

Q34369138-41D7CBDD-7824-468C-8146-CA780375D1F7

Q34369138-4DBE0E66-DD42-4CB3-AAC2-BB8AFAC7D2BF

Q34369138-51C6FF18-BA83-4DDC-8254-0B1D5D2E35AE

Q34369138-67E56058-F882-4D1E-B632-9A8FA6614C71

Q34369138-70A6B767-3CDD-42BA-B028-3EB4E0302DE2

Q34369138-83E2392D-DBDF-4C5E-8A5F-41005A091F1D

Q34369138-8D311036-073D-4469-B12A-62CACA848CFA

P2860

Q34369138-01DA5ED6-D881-4089-8D0B-2E48CA572EBE

Q34369138-08C45FCB-537A-4262-8D07-3EF1DCAC425D

Q34369138-0E88D01C-0041-419A-9406-291C15F377C2

Q34369138-114C48F9-10CD-4D54-8D23-7A641347CF92

Q34369138-19B817AD-D9E9-4313-A36D-62BFBBF91AAD

Q34369138-1C14C337-497E-46FD-95DA-2230CCC044C3

Q34369138-1EAFABA4-1BB1-4A8B-B96C-8D5D293FAA58

Q34369138-1F1B0CF5-1916-421B-AC0B-05D5A6929431

Q34369138-278DD2B4-7072-4CEE-9B4D-64153662830F

Q34369138-32FB3F44-6C7A-4DED-B6A2-AD44BE586493

P2888

Q34369138-F1BFC7B2-73A8-4BA7-9D2A-8A469DD5C8BA

P304

Q34369138-4BD1DEC0-118C-4D07-A209-5B3073D6758D

P31

Q34369138-8E67B5EC-5F07-42BD-9CB9-899FDE5D43AA

P356

Q34369138-A7AC372F-722D-4581-85A4-060EDF8CFC07

P407

Q34369138-E9BAAC8B-0B4F-4171-9961-81BB5D9CD121

P433

Q34369138-CE0A529B-6552-4147-BA9E-FB6393D59D50

P478

Q34369138-5FA683DA-9E61-4302-8D87-7E93E7E018F0

P50

Q34369138-66E7557F-718C-4EA0-AC26-CE487328907B

P577

Q34369138-7FAA57A8-0E80-497D-9CE1-8B8B3FCE0A79

P5875

Q34369138-AEE5F9AB-C63C-48B4-A704-9283C57E711F

P6179

Q34369138-CC0E456B-3986-426B-A9FE-1DD01E60FE5C

P698

Q34369138-7DC3A252-A042-4B6C-A29A-F73EC97BFF82

P921

Q34369138-48397707-171B-4A88-8B29-EC4BDAE9AB62

P932

Q34369138-4203432A-8BC9-4CDA-BA19-7CDB11117768

P356

S10549-009-0436-8

P1433

Breast Cancer Research and Treatment

P1476

Androgen receptor overexpressi ...... in human breast cancer cells.

@en

P2093

Amanda Beyer

http://www.w3.org/2001/XMLSchema#string

Francesca De Amicis

http://www.w3.org/2001/XMLSchema#string

Gary C Chamness

http://www.w3.org/2001/XMLSchema#string

Irma Parra

http://www.w3.org/2001/XMLSchema#string

Janagi Thirugnansampanthan

http://www.w3.org/2001/XMLSchema#string

Jennifer Selever

http://www.w3.org/2001/XMLSchema#string

Matthew H Herynk

http://www.w3.org/2001/XMLSchema#string

Michael T Lewis

http://www.w3.org/2001/XMLSchema#string

Nancy L Weigel

http://www.w3.org/2001/XMLSchema#string

Sebastiano Andò

http://www.w3.org/2001/XMLSchema#string

P2860

Forkhead homologue in rhabdomyosarcoma functions as a bifunctional nuclear receptor-interacting protein with both coactivator and corepressor functions

Repressors of androgen and progesterone receptor action

Cyclin D1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients.

Tamoxifen functions as a molecular agonist inducing cell cycle-associated genes in breast cancer cells

Tamoxifen resistant breast cancer: coregulators determine the direction of transcription by antagonist-occupied steroid receptors.

Oestrogen and growth factor cross-talk and endocrine insensitivity and acquired resistance in breast cancer.

Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells.

Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer.

Bicalutamide (Casodex) in the treatment of prostate cancer.

Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy.

P2888

s10549-009-0436-8

P304

1-11

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10549-009-0436-8

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

121

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-06-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26298500

http://www.w3.org/2001/XMLSchema#string

P6179

1045273349

http://www.w3.org/2001/XMLSchema#string

P698

19533338

http://www.w3.org/2001/XMLSchema#string

P921

P932

2995248

http://www.w3.org/2001/XMLSchema#string